Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy

被引:29
|
作者
Romano, Maria [1 ,2 ]
Di Taranto, Maria Donata [3 ]
D'Agostino, Maria Nicoletta [1 ,2 ]
Marotta, Gennaro [4 ]
Gentile, Marco [4 ]
Abate, Giovanna [2 ]
Mirabelli, Peppino [1 ,2 ]
Di Noto, Rosa [1 ,2 ]
Del Vecchio, Luigi [1 ,2 ]
Rubba, Paolo [4 ]
Fortunato, Giuliana [1 ,2 ]
机构
[1] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy
[2] CEINGE SCarl Biotecnol Avanzate, Naples, Italy
[3] Fdn IRCCS SDN, Naples, Italy
[4] Univ Naples Federico 2, Dipartimento Med Clin & Sperimentale, Naples, Italy
关键词
LDL receptor; Familial hypercholesterolemia; Large rearrangements; LDL uptake assay; RECEPTOR GENE-MUTATIONS; POPULATION;
D O I
10.1016/j.atherosclerosis.2009.11.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) gene, in the apolipoprotein B-100 gene or in the proprotein convertase subtilisin/kexin type 9 gene. The aim of this study was to identify and functionally characterize mutations in the LDLR gene that account for most cases of familial hypercholesterolemia (FH). Methods: We enrolled 56 unrelated patients from Southern Italy with a clinical diagnosis of FH. The mutation screening was performed by direct sequencing of the promoter and the 18 exons of the LDLR gene and by multiplex ligation-dependent probe amplification (MLPA) analysis to search for large rearrangements. Results and conclusion: We found 5 new mutations, the causative role of which was demonstrated by functional characterization performed by quanti. cation of fluorescent LDL uptake in EBV-transformed B lymphocytes. These results enlarge the spectrum of FH-causative LDLR mutations. Lastly, screening for large rearrangements is highly recommended for the genetic diagnosis of FH. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:493 / 496
页数:4
相关论文
共 50 条
  • [1] Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations
    Chmara, M.
    Wasag, B.
    Zuk, M.
    Kubalska, J.
    Wegrzyn, A.
    Bednarska-Makaruk, M.
    Pronicka, E.
    Wehr, H.
    Defesche, J. C.
    Rynkiewicz, A.
    Limon, J.
    JOURNAL OF APPLIED GENETICS, 2010, 51 (01) : 95 - 106
  • [2] Functional analysis of LDLR promoter mutations and their relationship with familial hypercholesterolemia
    de Castro-Oros, Isabel
    Bolado-Carrancio, Alfonso
    Pampin, Sandra
    Palacios, Lourdes
    Plana, Nuria
    de Cubas, Aguirre
    Martorell, Esperanza
    Puzo, Jose
    Stef, Marianne
    Masana, Luis
    Civeira, Fernando
    Carlos Rodriguez-Rey, Jose
    Pocovi, Miguel
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2011, 23 (03): : 119 - 124
  • [3] Identification of LDLR mutations in two Chinese pedigrees with familial hypercholesterolemia
    Yao, Ru-en
    Wang, Jian
    Geng, Juan
    Zheng, Zhaojing
    Yu, Tingting
    Yu, Yongguo
    Fu, Qihua
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (7-8): : 769 - 773
  • [4] FUNCTIONAL ANALYSIS OF LDLR PROMOTER MUTATIONS ASSOCIATED WITH FAMILIAL HYPERCHOLESTEROLEMIA
    De Castro-Oros, I.
    Palacios, L.
    Pampin, S.
    Plana, N.
    Masana, L.
    Stef, M.
    Civeira, F.
    Rodriguez-Rey, J. C.
    Pocovi, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 113 - 113
  • [5] MOLECULAR CHARACTERIZATION OF POLISH PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: NOVEL AND RECURRENT LDLR GENE MUTATIONS
    Chmara, M.
    Kubalska, J.
    Bednarska-Makaruk, M.
    Wegrzyn, A.
    Pronicka, E.
    Wehr, A.
    Rynkiewicz, A.
    Limon, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 111 - 111
  • [6] Functional characterization of 3′UTR LDLR variants in Familial Hypercholesterolemia
    Sanguino, Javier
    Rodriguez-Jimenez, Carmen
    Mostaza, Jose Maria
    Sevilla, Elena
    Herranz-Cecilia, Amanda
    Carazo, Ana
    Pernia, Olga
    Rodriguez-Antolin, Carlos
    Ibanez, Inmaculada
    Rodriguez-Novoa, Sonia
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 208 - 208
  • [7] MIRNOME STUDY AND FUNCTIONAL CHARACTERIZATION OF LDLR: AN INTEGRATED APPROACH TO IDENTIFY PATHOGENICITY MECHANISMS IN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITHOUT CAUSATIVE MUTATIONS
    Di Taranto, M. D.
    Giacobbe, C.
    di Frega, A. Scotto
    Cordella, A.
    Giurato, G.
    Rubba, P.
    Weisz, A.
    Fortunato, G.
    ATHEROSCLEROSIS, 2018, 275 : E23 - E23
  • [8] CHARACTERIZATION OF THE EFFECTS OF FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS IN LDLR ON PCSK9 BINDING
    Deng, Shijun
    Alabi, Adekunle
    Zhang, Dawei
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 55 - 55
  • [9] Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations
    Callis, M
    Jansen, S
    Thiart, R
    de Villiers, JNP
    Raal, FJ
    Kotze, MJ
    MOLECULAR AND CELLULAR PROBES, 1998, 12 (03) : 149 - 152
  • [10] Frequency of the most common mutations in the LDLR gene in patients with familial hypercholesterolemia from RN Macedonia
    Kiprijanovska, Sanja
    Shehu, Enes
    Dichevska, Hristina
    Vavlukis, Marija
    Kedev, Sasko
    Dimovski, Aleksandar
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 155 - 155